AllPennyStocks.com RARE Stock Jumps 6% After-Hours On First Gene Therapy Approval, New Priority Review Voucher
This section contains press releases and other materials from third parties (including paid content). AllPennyStocks.com has not reviewed this content. Please see our disclaimer.

RARE Stock Jumps 6% After-Hours On First Gene Therapy Approval, New Priority Review Voucher

The FDA granted accelerated approval to GENGLYCOS, also called DTX401, for patients aged eight and older with glycogen storage disease type Ia (GSDIa).

Other Penny Stock Movers

A $1 Billion Crypto Deal Sends This Microcap Surging
This Microcap Just Pulled Core From One of Copper's Last Frontiers
Target Expansion and Geophysics Survey Trigger 18% Surge for Norwegian Base-Metal Project
Most Popular
{{ index + 1 }}


Back to Top